----

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION****Washington, D.C.  20549**

----

**AMENDMENT NO. 2**

**FORM 10-QSB/A**

**QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

| **For   the Quarterly Period Ended September 30, 2005** | **Commission File Number    1-13524** |
|---------------------------------------------------------|--------------------------------------------|

| **TIMELINE,   INC.**                                                    |
|-------------------------------------------------------------------------|
| **(Exact   name of small business issuer as specified in its charter)** |
|                                                                    |   |   |
| **Washington**                                                          |   | **91-1590734** |
| **(State or   other jurisdiction of   incorporation or organization)**  |   | **(IRS   Employer    Identification No.)** |
|                                                                    |   |   |
| **1700 Seventh Avenue, Ste. 2100   Seattle, WA  98101**            |
| **(Address   of principal executive offices)**                          |
|                                                                    |
| **(206) 357-8422**                                                      |
| **(Issuer’s   telephone number)**                                  |
|                                                                    |
| **3055 112th Avenue N.E., Suite 106   Bellevue, WA  98004**        |
| **(Former   Address, if Changed Since Last Report)**                    |

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  

| Yes  x | No  o |
|------------------|-----------------|

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

| Yes  o | No  x |
|------------------|-----------------|

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date:

| **Class**                    |   | **Outstanding   at October 30, 2005** |
|------------------------------|--------|---------------------------------------|
|                              |   |                                       |
| Common Stock, $.01 Par Value |   | 4,190,998                             |
|                         |   |                                  |
|                              |

**EXPLANATORY NOTE:**

We are filing this Amendment No. 2 to our Quarterly Report on Form 10-QSB/A for the quarter ended September 30, 2005 (as originally filed on November 14, 2005, the “Original Report”), in response to communications with the Securities and Exchange Commission regarding accounting treatment on gains from our asset sale with Global Software Inc. in August 2005.

As previously reported, we entered into an Asset Purchase Agreement with Global Software Inc. on July 20, 2005, for the sale to Global of all of our software licensing operations.  (A copy of the Asset Purchase Agreement was filed as an exhibit to our Current Report on Form 8-K, as filed with the SEC on July 25, 2005.)  Under the terms of the Asset Purchase Agreement, $480,000 of the total purchase price was allocated to our covenant not to compete with the business segment being sold for a period of 48 months following closing.  The Asset Sale was consummated on August 31, 2005.

Originally, we treated this $480,000 of gain allocated to the covenant not to compete as “deferred revenue”, with $10,000 per month being recognized as revenue ratably over the 48-month non-compete period.  As a result, on the Condensed Consolidated Balance Sheet as of September 31, 2005 in the Original Report, we recorded $10,000 of revenue and the remaining $470,000 unamortized portion was shown as a liability under “deferred revenue”.

After discussion with the company’s auditors, we have reclassified this $480,000 as “gain on asset sale” rather than deferred revenues.  The net effect of this reclassification, as reported in this Amendment No. 2, is as follows:

|          (1) With   respect to our Condensed Statement of Operations, for each of the three- and   six-month periods ended September 30, 2005, this reclassification results in: |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                                                                               | • | an increase in the amount of “Gain on Asset Sale” by   $480,000, and |
|                                                                                                                                                                                                                               | • | a decrease in “Warranty Revenues” of $10,000,   resulting in |
|                                                                                                                                                                                                                               | • | an increase in “Net Income” by $470,000 (to   $2,127,353 and $1,892,699, respectively, for each of the three- and six-month   periods ended September 30, 2005) and an increase in “Net income per share”   by $0.11 per share (to $0.51 and $0.44, respectively, for each of the three-   and six-month periods ended September 30, 2005). |

|          (2) With   respect to our Condensed Consolidated Balance Sheet as of September 30, 2005,   this reclassification results in: |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                                                                    | • | a decrease of “Deferred revenue” (current   liabilities) by $470,000, and |
|                                                                                                                                                                                    | • | an decrease in “Accumulated deficit” of $470,000,   resulting in |
|                                                                                                                                                                                    | • | an increase in “Total shareholders’ equity” by   $470,000. |

This Form 10-QSB/A includes all of the information contained in the Original Report, and we have made no attempt in this Form 10-QSB/A to modify or update the disclosures presented in the Original Report, except as identified above.  The disclosures in this Form 10-QSB/A continue to speak as of the date of the Original Report, and do not reflect events occurring after the filing of the Original Report.  Accordingly, this Form 10-QSB/A should be read in conjunction with our other filings made with the Securities and Exchange Commission subsequent to the filing of the Original Filing, including any amendments to those filings.  The filing of this Form 10-QSB/A shall not be deemed an admission that the Original Report when made included any untrue statement of a material fact or omitted to state a material fact necessary to make a statement not misleading.

2

**PART I - FINANCIAL INFORMATION**

| **Item   1.** | **Financial   Statements** |
|---------------|----------------------------|

**TIMELINE, INC.**

**CONDENSED CONSOLIDATED BALANCE SHEETS**

|                                                                                                                  |   |                              |               |                            |   |               |   |
|-----------------------------------------------------------------------------------------------------------------------|--------|-----------------------------------|--------------------|---------------------------------|--------|--------------------|--------|
|                                                                                                                  |   | **As of    September 30,   2005** |               | **As of,    March 31,    2005** |   |
|                                                                                                                  |   |                                   |                    |                            |        |                    |   |
|                                                                                                                  |   | **(Unaudited)**                   |               |                            |   |
| ASSETS                                                                                                                |   |                              |               |                            |   |               |   |
| CURRENT ASSETS:                                                                                                       |   |                              |               |                            |   |               |   |
| Cash and cash   equivalents                                                                                           |   | $                                 | 790,628            |                            | $      | 121,390            |   |
| Accounts receivable,   net of allowance for doubtful accounts of $3,665 and $3,136                                    |   |                              | 78,975             |                            |   | 281,690            |   |
| Prepaid expenses and   other                                                                                          |   |                              | 53,795             |                            |   | 18,285             |   |
|                                                                                                                  |   |                                   |                    |                            |        |                    |   |
| Total current assets                                                                                                  |   |                              | 923,398            |                            |   | 421,365            |   |
| Property and equipment, net of accumulated   depreciation of $76,909 and $447,495                                     |   |                              | 3,143              |                            |   | 3,882              |   |
| Capitalized patents, net of accumulated amortization   of $95,238 and $82,786                                         |   |                              | 272,694            |                            |   | 265,911            |   |
| Long term notes receivable                                                                                            |   |                              | 1,008,252          |                            |   | —   |   |
| Other assets                                                                                                          |   |                              | 2,450              |                            |   | —   |   |
| Assets of discontinued operations                                                                                     |   |                              | —   |                            |   | 558,234            |   |
|                                                                                                                  |   |                                   |                    |                            |        |                    |   |
| Total assets                                                                                                          |   | $                                 | 2,209,937          |                            | $      | 1,249,392          |   |
|                                                                                                                  |   |                                   |                    |                            |        |                    |   |
| LIABILITIES AND SHAREHOLDERS’   EQUITY                                                                           |   |                              |               |                            |   |               |   |
| CURRENT LIABILITIES:                                                                                                  |   |                              |               |                            |   |               |   |
| Accounts payable                                                                                                      |   | $                                 | 18,340             |                            | $      | 56,865             |   |
| Accrued expenses                                                                                                      |   |                              | 48,341             |                            |   | 129,340            |   |
| Notes payable                                                                                                         |   |                              | 72,785             |                            |   | 61,327             |   |
|                                                                                                                  |   |                                   |                    |                            |        |                    |   |
| Total current   liabilities                                                                                           |   |                              | 139,466            |                            |   | 247,532            |   |
|                                                                                                                  |   |                                   |                    |                            |        |                    |   |
| Liabilities of discontinued   operations                                                                              |   |                              | —   |                            |   | 943,341            |   |
|                                                                                                                  |   |                                   |                    |                            |        |                    |   |
| Total Liabilities                                                                                                     |   |                              | 139,466            |                            |   | 1,190,873          |   |
| SHAREHOLDERS’ EQUITY:                                                                                            |   |                              |               |                            |   |               |   |
| Common stock, $.01 par   value, 20,000,000 shares authorized, 4,198,998 and 4,198,998 shares issued   and outstanding |   |                              | 41,910             |                            |   | 41,910             |   |
| Additional paid-in   capital                                                                                          |   |                              | 10,578,447         |                            |   | 10,578,447         |   |
| Accumulated other   comprehensive loss                                                                                |   |                              | —   |                            |   | (119,252           | )      |
| Accumulated deficit                                                                                                   |   |                              | (8,549,886         | )                               |   | (10,442,586        | )      |
|                                                                                                                  |   |                                   |                    |                            |        |                    |   |
| Total shareholders’   equity                                                                                     |   |                              | 2,070,471          |                            |   | 58,519             |   |
|                                                                                                                  |   |                                   |                    |                            |        |                    |   |
| Total liabilities and   shareholders’ equity                                                                     |   | $                                 | 2,209,937          |                            | $      | 1,249,392          |   |
|                                                                                                                  |   |                                   |                    |                            |        |                    |   |

The accompanying notes are an integral part of these financial statements.

3

**TIMELINE, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS**

**For the Three Months and Six Months Ended September 30, 2005 and 2004 (unaudited)**

|                                                                |   | **Three   Months Ended   September 30,** |               | **Six Months   Ended   September 30,** |   |
|---------------------------------------------------------------------|--------|------------------------------------------|--------------------|----------------------------------------|--------|
|                                                                |   |                                          |               |                                        |   |
|                                                                |   | **2005**                                 |               | **2004**                               |   | **2005** |   | **2004** |   |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |
| REVENUES:                                                           |   |                                     |               |                                   |   |   |   |   |   |   |   |   |   |
| Patent   license                                                    |   | $                                        | 272                |                                   | $      | —   |   | $ | 362 |   | $ | 3,092 |   |
| Consulting                                                          |   |                                     | 621                |                                   |   | —   |   |   | 621 |   |   | —   |   |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |
| Total   revenues                                                    |   |                                     | 893                |                                   |   | —   |   |   | 983 |   |   | 3,092 |   |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |
| COST OF REVENUES:                                                   |   |                                     |               |                                   |   |   |   |   |   |   |   |   |   |
| Patent   license                                                    |   |                                     | 6,268              |                                   |   | 5,487 |   |   | 12,452 |   |   | 10,890 |   |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |
| Total   cost of revenues                                            |   |                                     | 6,268              |                                   |   | 5,487 |   |   | 12,452 |   |   | 10,890 |   |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |
| Gross   loss                                                        |   |                                     | (5,375             | )                                      |   | (5,487 | ) |   | (11,469 | ) |   | (7,798 | ) |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |
| OPERATING EXPENSE:                                                  |   |                                     |               |                                   |   |   |   |   |   |   |   |   |   |
| General   and administrative                                        |   |                                     | 145,692            |                                   |   | 109,392 |   |   | 287,448 |   |   | 280,030 |   |
| Patents                                                             |   |                                     | 39,745             |                                   |   | 33,503 |   |   | 72,213 |   |   | 75,020 |   |
| Depreciation                                                        |   |                                     | 369                |                                   |   | 547 |   |   | 738 |   |   | 1,093 |   |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |
| Total   operating expenses                                          |   |                                     | 185,806            |                                   |   | 143,442 |   |   | 360,399 |   |   | 356,143 |   |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |
| Loss   from operations                                              |   |                                     | (191,181           | )                                      |   | (148,929 | ) |   | (371,868 | ) |   | (363,941 | ) |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |
| OTHER INCOME (EXPENSE):                                             |   |                                     |               |                                   |   |   |   |   |   |   |   |   |   |
| Interest   income (expense) and other                               |   |                                     | 13,658             |                                   |   | (4,609 | ) |   | 11,061 |   |   | (4,708 | ) |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |
| Total   other income (expense)                                      |   |                                     | 13,658             |                                   |   | (4,609 | ) |   | 11,061 |   |   | (4,708 | ) |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |
| Income   (loss) from continuing operations before income taxes      |   |                                     | 2,184,534          |                                   |   | (153,538 | ) |   | 2,001,250 |   |   | (368,649 | ) |
| Provision   for income tax                                          |   |                                     | —   |                                   |   | —   |   |   | —   |   |   | —   |   |
| Gain   on stock sale of discontinued operations                     |   |                                     | 1,287,132          |                                   |   | —   |   |   | 1,287,132 |   |   | —   |   |
| Gain   on asset sale of discontinued operations                     |   |                                     | 1,074,925          |                                   |   | —   |   |   | 1,074,925 |   |   | —   |   |
| (Loss)   income from discontinued operations,   net of income tax   |   |                                     | (57,181            | )                                      |   | 16,394 |   |   | (108,551 | ) |   | (159,181 | ) |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |
| Net   income (loss)                                                 |   | $                                        | 2,127,353          |                                   | $      | (137,144 | ) | $ | 1,892,699 |   | $ | (527,830 | ) |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |
| Basic net income (loss) per   common and common equivalent share    |   | $                                        | 0.51               |                                   | $      | (0.03 | ) | $ | 0.45 |   | $ | (0.13 | ) |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |
| Shares used in calculation   of basic net income (loss) per share   |   |                                     | 4,190,998          |                                   |   | 4,190,998 |   |   | 4,190,998 |   |   | 4,190,998 |   |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |
| Diluted net income (loss)   per common and common equivalent share  |   | $                                        | 0.51               |                                   | $      | (0.03 | ) | $ | 0.45 |   | $ | (0.13 | ) |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |
| Shares used in calculation   of diluted net income (loss) per share |   |                                     | 4,190,998          |                                   |   | 4,190,998 |   |   | 4,190,998 |   |   | 4,190,998 |   |
|                                                                |   |                                          |                    |                                   |        |  |   |  |  |   |  |  |   |

The accompanying notes are an integral part of these financial statements.

4

**TIMELINE, INC.**

**CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS**

**For the Six Months Ended September 30, 2005 and 2004 (unaudited)**

|                                                  |   | **2005** |               | **2004** |   |
|-------------------------------------------------------|--------|----------|--------------------|----------|--------|
|                                                  |   |          |                    |     |        |  |   |
| CASH FLOWS FROM OPERATING ACTIVITIES                  |   |     |               |     |   |   |   |
| Net cash provided by   (used in) operating activities |   | $        | 1,739,098          |     | $      | (295,090 | ) |
| CASH FLOWS FROM DISCONTINUED OPERATIONS               |   |     |               |     |   |   |   |
| Net cash used in discontinued   operations            |   |     | (108,550           | )        |   | (159,181 | ) |
| CASH FLOWS FROM INVESTING ACTIVITIES                  |   |     |               |     |   |   |   |
| Capitalized patent   acquisition costs                |   |     | (19,235            | )        |   | (17,672 | ) |
| Line of credit   borrowings                           |   |     | —   |     |   | 40,250 |   |
| Line of credit   repayments                           |   |     | (61,327            | )        |   | (3,840 | ) |
| Notes receivable                                      |   |     | (1,000,000         | )        |   | —   |   |
|                                                  |   |          |                    |     |        |  |   |
| Net cash (used in) from   investing activities        |   |     | (1,080,562         | )        |   | 18,738 |   |
|                                                  |   |          |                    |     |        |  |   |
| CASH FLOWS FROM FINANCING ACTIVITIES                  |   |     |               |     |   |   |   |
| Issuance of common   stock warrants                   |   |     | —   |     |   | 4,725 |   |
|                                                  |   |          |                    |     |        |  |   |
| Net cash provided by   financing activities           |   |     | —   |     |   | 4,725 |   |
| EFFECT OF FOREIGN EXCHANGE RATE                       |   |     | 119,252            |     |   | 8,807 |   |
| NET CHANGE IN CASH AND CASH EQUIVALENTS               |   |     | 669,238            |     |   | (422,001 | ) |
| CASH AND CASH EQUIVALENTS, beginning of period        |   |     | 121,390            |     |   | 465,561 |   |
|                                                  |   |          |                    |     |        |  |   |
| CASH AND CASH EQUIVALENTS, end of period              |   | $        | 790,628            |     | $      | 43,560 |   |
|                                                  |   |          |                    |     |        |  |   |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:     |   |     |               |     |   |   |   |
| Cash paid for interest                                |   | $        | 2,129              |     | $      | 724 |   |

The accompanying notes are an integral part of these financial statements

5

**TIMELINE, INC.**

**NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS**

**September 30, 2005**

**1.  THE COMPANY**

Organization

The accompanying consolidated financial statements are for Timeline, Inc. and subsidiaries (the Company).  The Company, headquartered in Seattle, Washington, licenses intellectual property protected by patents granted by the U.S. Patent and Trademark Office and six other countries.  Prior to August 31, 2005, the Company also developed, marketed and supported enterprise-wide financial management, budgeting and reporting software and event-based notification, application integration and process automation systems, and prior to July 20, 2005, had operations in the United Kingdom.

Operations

The Company has historically suffered recurring operating losses and negative cash flows from operations.  As of September 30, 2005, the Company had net working capital of approximately $784,000 and had an accumulated deficit of approximately $8,550,000 with total shareholders’ equity of approximately $2,070,000.  These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, assuming that the Company will continue as a going concern.  Our auditors for fiscal year ended March 31, 2005, added an explanatory paragraph to their opinion on our fiscal 2005 financial statements stating that there was substantial doubt about our ability to continue as a going concern.

On July 20, 2005, the Company entered into an Asset Purchase Agreement with Global Software, Inc. (“Global”) for the sale to Global of all of its software licensing operations.  (A copy of the Asset Purchase Agreement was filed as an exhibit to a Current Report on Form 8-K, as filed with the SEC on July 25, 2005.)  Under the terms of the Asset Purchase Agreement, the sale of the Company’s software business occurred in two stages, consisting of (1) the sale of 100% of stock in its U.K. subsidiary, Analyst Financials Limited, and certain other assets and customer contracts (the “Stock Sale”), and (2) the sale of its other software assets (the “Asset Sale”), in each case in exchange for cash, promissory notes, and assumption of certain liabilities.  The Stock Sale was consummated on July 20, 2005.  The Asset Sale was approved by the Company’s shareholders at its annual meeting on August 30, 2005,and was consummated on August 31, 2005.  The Company retains such assets as required to continue its patent licensing operations.  The Stock Sale and the Asset Sale are reported in the Company’s financial statements in the current period.  Operations of the software business conducted by the Company and its subsidiaries during the periods covered in these financial statements are shown as discontinued operations.

The Company continues in the business of licensing its intellectual property which consists of a portfolio of patents granted in seven different countries.  This line of business has previously generated approximately $14 million in total patent license fees since March 1998.  However, patent licensing tends to be very litigious in nature and, as such, revenue generation has been sporadic.   

6

With the net proceeds the Company received from the Stock Sale on July 20, 2005 and the Asset Sale on August 31, 2005, management believes that current cash and cash equivalent balances, and any net cash provided by continuing operations, will provide adequate resources to fund operations through March 31, 2006.  

**2.  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES:**

**Interim Financial Statements**

The accompanying condensed consolidated financial statements of the Company are unaudited.  In the opinion of the Company’s management, the financial statements include all adjustments, including those described in Note 6 to reflect the discontinued line of business, necessary to state fairly the financial information set forth in this Report in conformity with accounting principles generally accepted in the United States of America.  Results of operations for the six-month period ended September 30, 2005 are not indicative of future financial results due to the change in business operations as explained above.

Certain notes and other information have been condensed or omitted from the interim financial statements presented in this Quarterly Report on Form 10-QSB.  Accordingly, these financial statements should be read in conjunction with the Company’s annual financial statements for the year ended March 31, 2005, as previously reported in the Company’s Form 10-KSB/A.

**Use of Estimates**

The process of preparing financial statements in conformity with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions regarding certain types of assets, liabilities, revenues, and expenses.  Such estimates primarily relate to unsettled transactions and events as of the date of the financial statements.  Accordingly, upon settlement, actual results may differ from estimated amounts.

**Basis of Presentation**

All subsidiaries of the Company are wholly-owned.  The Company’s subsidiaries did not generate any revenue or expense for the period reflected in the accompanying consolidated financial statements.

**Revenue Recognition**

The Company recognizes revenue generated from the licensing of patents when a patent license agreement is signed, collectibility is probable and the amount of payment is fixed and determinable, consistent with SOP 97-2 and Staff Accounting Bulletin (SAB) No.101, “Revenue Recognition” (SAB 101).  

For all licenses, the Company uses a signed agreement as evidence of an arrangement.  At the time of each transaction, the Company assesses whether the fee associated with its revenue transactions is fixed and determinable and whether or not collection is reasonably assured.  The Company assesses whether the fee is fixed and determinable based on the payment terms associated with the transaction.  If a significant portion of a fee is due after the Company’s normal payment terms, the Company accounts for the fee as not being fixed and determinable.  In these cases, it defers revenue and recognizes it when it becomes due and payable.

7

The Company assesses the probability of collection based on a number of factors including the current financial condition of the customer.  It does not request collateral from its customers.  If the Company determines that collection of a fee is not reasonably assured, it defers revenue until the time collection becomes reasonably assured.

**Net Income (Loss) per Common Share**

Basic and diluted net income (loss) per share is the net income or loss divided by the weighted average number of shares outstanding during the period. The effect of including outstanding options and warrants is anti-dilutive for all periods presented.  

Shares issuable pursuant to stock options and warrants that have not been included in the calculation of net loss per share because they are antidilutive totaled 518,500 and 596,500 for the three-month periods ended September 30, 2005 and 2004, respectively.  

**Stock-Based Compensation**

The Company applies the intrinsic value based method of accounting prescribed by APB Opinion No. 25, “Accounting for Stock Issued to Employees” (APB No. 25), and related interpretations including FASB Interpretation No. 44, “Accounting for Certain Transactions involving Stock Compensation, and interpretation of APB Opinion No. 25” (FIN No. 44), to account for its fixed plan stock options.  Under this method, compensation expense is recorded on the date of grant only if the current market price of the underlying stock exceeded the exercise price.  Compensation costs for fixed awards with pro rata vesting are recognized using the straight-line method.  SFAS No. 123, “Accounting for Stock Based Compensation” (SFAS No. 123), established accounting and disclosure requirements using a fair value based method of accounting for stock based employee compensation plans.  As allowed by SFAS No. 123, the Company has elected tocontinue to apply the intrinsic-value-based method of accounting described above, and has adopted only the disclosure requirements of SFAS No. 123.   The following table illustrates the effect on net income (loss) if the fair-value-based method had been applied to all outstanding and unvested awards in each of the three- and six-month periods ended September 30, 2004 and 2005, respectively:

|                                                                                                               |   | **Three   Months Ended** |               | **Six Months   Ended** |   |
|--------------------------------------------------------------------------------------------------------------------|--------|--------------------------|--------------------|------------------------|--------|
|                                                                                                               |   |                          |               |                        |   |
|                                                                                                               |   | **Sept. 30,   2005**     |               | **Sept. 30,   2004**   |   | **Sept. 30,   2005** |   | **Sept. 30,   2004** |   |
|                                                                                                               |   |                          |                    |                   |        |  |   |  |  |   |  |  |   |
| Net income (loss), as   reported                                                                                   |   | $                        | 2,127,353          |                   | $      | (137,144 | ) | $ | 1,892,699 |   | $ | (527,830 | ) |
| Add stock-based employee   compensation expense included in reported net income (loss)                             |   |                     | —   |                   |   | —   |   |   | —   |   |   | —   |   |
| Deduct total stock-based   employee compensation expense determined under fair-value based method for   all awards |   |                     | —   |                   |   | —   |   |   | —   |   |   | —   |   |
|                                                                                                               |   |                          |                    |                   |        |  |   |  |  |   |  |  |   |
| As   adjusted net income (loss)                                                                                    |   | $                        | 2,127,353          |                   | $      | (137,144 | ) | $ | 1,892,699 |   | $ | (527,830 | ) |
|                                                                                                               |   |                          |                    |                   |        |  |   |  |  |   |  |  |   |
| Shares used in basic and   diluted net income (loss) per share                                                     |   |                     | 4,190,998          |                   |   | 4,190,998 |   |   | 4,190,998 |   |   | 4,190,998 |   |
|                                                                                                               |   |                          |                    |                   |        |  |   |  |  |   |  |  |   |
| Basic and diluted net   income (loss) per share as reported                                                        |   | $                        | 0.51               |                   | $      | (0.03 | ) | $ | 0.45 |   | $ | (0.13 | ) |
|                                                                                                               |   |                          |                    |                   |        |  |   |  |  |   |  |  |   |

8

In April 2003, in connection with a software license with Fidelity National Information Solutions (Nasdaq:FNIS), Timeline issued a warrant to FNIS to buy up to 100,000 shares of Timeline stock at $1.62 per share and, upon appropriate notice, to appoint either an observer or member to the Timeline Board of Directors.  The warrants were fully vested upon issuance.  The fair value of each warrant was established on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions: zero dividend yield; expected volatility of 91%; risk-free interest rate of 2.78%, and a contractual life of 4 years.  These warrants expire if not exercised by April 2007.  The aggregate fair value of these warrants was approximately $84,000 and was recognized as a reduction to license revenue recognized in the first quarter of fiscal 2004.

In September 2004, the Company entered into a financing agreement with Silicon Valley Bank.  As part of the financing agreement, a warrant to purchase up to 7,500 shares of the Company’s common stock at $0.80 per share was issued.  The warrant was fully vested upon issuance.  The fair value of the warrant was established on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions: zero dividend yield; expected volatility of 91%; risk-free interest rate of 2.78%, and a contractual life of 7 years.  The warrant expires if not exercised by September 23, 2011.  The fair value of the warrant was approximately $4,725 and was recognized as interest expense in the second quarter of fiscal 2005.

**Impairment of Long-lived Assets**

In accordance with Statement of Financial Accounting Standards No. 144, “Accounting for the Impairment or Disposal of Long-Lived Assets” (SFAS No. 144), the Company evaluates long-lived assets, including intangible assets other than goodwill, for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable based on estimated undiscounted cash flows attributable to that asset.  The amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset.  The Company does not currently believe that any of its long-lived assets are impaired. 

**3.**  **LINE OF CREDIT **

On September 23, 2004, the Company entered into an Accounts Receivable Financing Agreement with Silicon Valley Bank.  Under the terms of the financing, the Company was able to borrow up to a maximum of $350,000, limited to 80% of its then qualified receivables.  Qualified receivables were generally trade receivables from U.S. customers not outstanding more than 90 days.  In connection with the Financing Agreement, the Company granted the lender a security interest in all of the Company’s assets and also granted the lender a warrant to purchase 7,500 shares of the Company’s common stock.  At September 30, 2004, the amount outstanding on the facility was $36,410.  On June 2, 2005, the line of credit and security interest was terminated and paid in full, and no amounts were outstanding as of September 30, 2005.  

**4.  GUARANTEES**

In November 2002, the FASB issued Interpretation No. 45, “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness to Others, an interpretation of FASB Statements No. 5, 57 and 107 and a rescission of FASB Interpretation No. 34” (FIN No. 45).  FIN 45 provides expanded accounting guidance surrounding liability recognition and disclosure requirements related to guarantees, as defined by this Interpretation.  In the ordinary course of business, the Company is not subject to potential obligations under guarantees that fall 

9

within the scope of FIN 45 except for standard indemnification and warranty provisions that are contained within many of its former customer software license and service agreements, and give rise only to the disclosure requirements prescribed by FIN 45.  In connection with Timeline’s sale of its software licensing business to Global Software, Timeline agreed in the Asset Purchase Agreement to indemnify Global for certain warranty claims that may be made under these customer software license and service agreements being sold to Global.  As of September 30, 2005, no such warranty or indemnification claims had been made against Timeline.

Indemnification and warranty provisions contained within the Company’s customer software license and service agreements are generally consistent with those prevalent in its industry.  The duration of its product warranties generally does not exceed 90 days following delivery of its products.  The Company has not incurred significant obligations under customer indemnifications or warranty provisions historically and does not expect to incur significant obligations in the future.  Accordingly, the Company does not maintain accruals for potential customer indemnifications or warranty-related obligations.

**5.  LITIGATION**

In June 2005, the Company filed an action in the Federal District Court for the Western District of Washington against ProClarity Corporation alleging infringement of certain of its patents.  The Company intends to seek monetary damages and an injunction against ProClarity licensing certain of its products.  A trial date of September 1, 2006 has been set but is subject to change at the court’s discretion.

From time to time, the Company may pursue litigation against other third parties to enforce or protect its rights under this patent or its intellectual property rights generally.

**6.  RESTATEMENT TO REFLECT DISCONTINUED LINE OF BUSINESS**

During the quarter ended September 30, 2005, Timeline sold all of its software licensing operations to Global Software, Inc.  The Stock Sale closed on July 20, 2005, and the Asset Sale closed on August 31, 2005.  In conformity with generally accepted accounting principals, the Company has accounted for the disposition of its software operations as the disposition of a significant portion of its business.  

10

The assets and liabilities of the discontinued line of business were as follows:

|                                                         |   | **As of   September 30, 2005** |               | **As of   March 31, 2005** |   |
|--------------------------------------------------------------|--------|--------------------------------|--------------------|----------------------------|--------|
|                                                         |   |                                |                    |                       |        |  |   |
| Assets                                                       |   |                           |               |                       |   |   |   |
| Cash and cash equivalents                                    |   | $                              | —   |                       | $      | 40,965 |   |
| Accounts receivable – net                               |   |                           | —   |                       |   | 361,634 |   |
| Goodwill – net                                          |   |                           | —   |                       |   | 70,183 |   |
| Other assets                                                 |   |                           | —   |                       |   | 85,452 |   |
|                                                         |   |                                |                    |                       |        |  |   |
| Total assets discontinued operations                         |   |                           | —   |                       |   | 558,234 |   |
|                                                         |   |                                |                    |                       |        |  |   |
| Liabilities                                                  |   |                           |               |                       |   |   |   |
| Accounts payable                                             |   |                           | —   |                       |   | 262,016 |   |
| Deferred revenue                                             |   |                           | —   |                       |   | 681,325 |   |
|                                                         |   |                                |                    |                       |        |  |   |
| Total liabilities of discontinued operations                 |   |                           | —   |                       |   | 943,341 |   |
|                                                         |   |                                |                    |                       |        |  |   |
| Liabilities in excess of assets of discontinued   operations |   | $                              | —   |                       | $      | (385,107 | ) |
|                                                         |   |                                |                    |                       |        |  |   |

Condensed results of the discontinued line of business were as follows: 

|                              |   | **Six months   Ended    September 30, 2005** |               | **Six months   Ended    September 30, 2004** |   |
|-----------------------------------|--------|----------------------------------------------|--------------------|----------------------------------------------|--------|
|                              |   |                                              |                    |                                         |        |  |   |
| Revenues                          |   | $                                            | 1,023,964          |                                         | $      | 1,550,180 |   |
| Cost of revenues                  |   |                                         | (185,704           | )                                            |   | (197,031 | ) |
|                              |   |                                              |                    |                                         |        |  |   |
| Gross profit                      |   |                                         | 838,260            |                                         |   | 1,353,149 |   |
| Operating expenses                |   |                                         | (883,175           | )                                            |   | (1,501,132 | ) |
| Other – foreign exchange     |   |                                         | (63,636            | )                                            |   | (11,198 | ) |
| Income taxes                      |   |                                         | —   |                                         |   | —   |   |
|                              |   |                                              |                    |                                         |        |  |   |
| Loss from discontinued operations |   | $                                            | (108,551           | )                                            | $      | (159,181 | ) |
|                              |   |                                              |                    |                                         |        |  |   |

The cash flows of the discontinued line of business were as follows:

|                                 |   | **Six months   Ended   September 30, 2005** |     | **Six months   Ended    September 30, 2004** |   |
|--------------------------------------|--------|---------------------------------------------|----------|----------------------------------------------|--------|
|                                 |   |                                             |          |                                         |        |  |   |
| Cash used in operations              |   | $                                           | (44,915  | )                                            | $      | (147,983 | ) |
| Effect of foreign exchange and other |   |                                        | (63,635  | )                                            |   | (11,198 | ) |
|                                 |   |                                             |          |                                         |        |  |   |
| Cash used in discontinued operations |   | $                                           | (108,550 | )                                            | $      | (159,181 | ) |
|                                 |   |                                             |          |                                         |        |  |   |

11

| **Item 2.** | **Management’s Discussion and   Analysis or Plan of Operations** |
|-------------|-----------------------------------------------------------------------|

*This Quarterly Report on Form 10-QSB includes a number of forward-looking statements that reflect our current views with respect to business strategies, products, future events and financial performance.  These forward-looking statements are subject to certain risks and uncertainties, including those discussed below, that could cause actual results to differ materially from historical results or those anticipated, including the risks and uncertainties described below, as well as in our annual report on Form 10-KSB/A for the year ended March 31, 2005, under the respective caption “Other Factors that May Affect Operating Results.”  When used in this Report, the words “anticipate,” “believe,” “predict,” “intend,” “may,” “could,” “should,” “would,” “will,” “expect,” “future,” “continue,” and variations of such words andsimilar expressions as they relate to the Company are intended to identify such forward-looking statements, but are not the exclusive means of identifying such statements.  Our actual results, performance or achievements could differ materially from the results expressed in, or implied by, these forward-looking statements.  We do not undertake any obligation to revise these forward-looking statements to reflect any future events or circumstances.  In addition, the disclosures under the caption “Other Factors that May Affect Operating Results” consist principally of a brief discussion of risks which may affect future results and are thus, in their entirety, forward-looking in nature.  **To facilitate readers in identifying forward-looking statements in this Report, we have attempted to mark sentences containing such statements with a single asterisk and paragraphs containing only forward-looking statements with double asterisks.  However, no assurance can be made allsuch statements have been identified and marked. **Therefore, readers are urged to carefully review and consider the various disclosures made in this report and in our other reports previously filed with the Securities and Exchange Commission (the “SEC”), including our periodic reports on Forms 10-KSB and 10-QSB, and those described from time to time in our press releases and other communications, which attempt to advise interested parties of the risks and factors that may affect the Company’s business.*

**OVERVIEW**

Timeline, Inc., headquartered in Seattle, Washington, licenses intellectual property protected by patents granted by the U.S. Patent and Trademark Office and six other countries.  We currently hold six patents issued by the U.S. Patent and Trademark Office on our technology (for a total of 136 issued claims), and we have also been issued patents in Australia, Canada, China, Hong Kong, Israel, Mexico and Singapore.  Our wholly owned subsidiary, WorkWise also holds one U.S. patent.  We have a number of pending patent applications, and believe additional international patents may be issued during fiscal 2006.*

Prior to August 31, 2005, we also developed, marketed and supported enterprise-wide financial management, budgeting and reporting software and event-based notification, application integration and process automation systems.  

On July 20, 2005, we entered into an Asset Purchase Agreement with Global Software, Inc. for the sale to Global of all of our software licensing operations.  (A copy of the Asset Purchase Agreement has been filed as an exhibit to a Current Report on Form 8-K, as filed with the SEC on July 25, 2005.)  Under the terms of the Asset Purchase Agreement, the sale of our software business occurred in two stages, consisting of (1) the sale of 100% of stock in our U.K. subsidiary, Analyst Financials Limited, and certain other assets and customer contracts (the “Stock Sale”), and (2) the sale of our other software assets (the “Asset Sale”), in each case in exchange for cash, promissory notes, and assumption of certain liabilities.  The Stock Sale was consummated on July 20, 2005 and the Asset Sale was consummated on August 31, 2005.

12

With the net proceeds we received from the Stock Sale on July 20, 2005 and the Asset Sale on August 31, 2005, as discussed in notes 1 and 6 to the financial statements included herein, we believe that our current cash and cash equivalents, together with any net cash provided by operations, will be sufficient to meet anticipated cash needs for working capital and capital expenditures through fiscal 2006.**  

**CRITICAL ACCOUNTING POLICIES AND ESTIMATES**

*The discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.  On an on-going basis, we evaluate our estimates including, among others, those affecting revenues, the allowance for doubtful accounts, and the useful lives of tangible and intangible assets.  The discussion below is intended as a brief discussion of some of the judgments and uncertainties that can impact the application of these policies and the specific dollar amounts reported on our financial statements.  We base our estimates on historical experience and on various otherassumptions that we believe to be reasonable under the circumstances, the results of which form our basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.  Actual results may differ from these estimates under different assumptions or conditions, or if management made different judgments or utilized different estimates.  Our estimates or judgments are based in part on anticipated future events or performance, and as such are forward-looking in nature, and are subject to many risks and uncertainties, including those discussed below and elsewhere in this Report.  We do not undertake any obligation to update or revise this discussion to reflect any future events or circumstances.*

We have identified the policies below as critical to our business operations and the understanding of our results of operations.  The impact and any associated risks related to these policies on our business operations is discussed throughout Management’s Discussion and Analysis or Plan of Operations where such policies affect our reported and expected financial results.  For a detailed discussion on the application of these and our other accounting policies, see the Notes to Condensed Consolidated Financial Statements of this Form 10-QSB and Note 2 to the Consolidated Financial Statements in our Annual Report on Form 10-KSB for the year ended March 31, 2005.

**Revenue Recognition**

We recognize revenue when persuasive evidence of an arrangement exists and delivery has occurred, provided the fee is fixed or determinable, and collectibility is probable.  We assess whether the fee is fixed and determinable based on the payment terms associated with the transaction.  If a fee is based upon a variable such as a royalty based on units sold, we account for the fee as not being fixed and determinable.  In these cases, we defer revenue and recognize it when it becomes due and payable.  We assess the probability of collection based on a number of factors, including past transaction history with the licensee and the current financial condition of the licensee.  We do not request collateral from our licensees.  If we determine that collection of a fee is not reasonably assured, we defer revenue until the time collection becomes reasonably assured.

For all patent licenses, we use a signed agreement, as evidence of an arrangement.  

13

**Allowance for Doubtful Accounts**

We estimate the uncollectibility of our accounts receivable by analyzing licensee credit-worthiness, current economic trends and changes in our license payment terms in order to evaluate the adequacy of the allowance for doubtful accounts.  Historically, we have experienced a minimal rate of doubtful accounts and therefore provide for an allowance of a set percentage based on aging of the receivable, i.e., 1% for receivables within 60 days of due date and 5% for those 61 days or more past the due date.  However, material differences may result in the amount and timing of our bad debt expenses for any period if we had an increase in unpaid accounts, which could reduce our total current assets.*  In fiscal 2004 or 2005, no bad debt expense was recorded against our bad debt reserves.  Nevertheless, if we underestimated the collectibility of our accounts receivable, it would have a negative impact on our reported net receivables, net loss and ourcash flow.*

**Capitalized Patents**

We capitalize the direct out-of-pocket costs to obtain patents on our technology.  Such costs are amortized over the life of the patent, which has a typical contractual life of 20 years.  Should we determine that we will not be able to generate future revenues as a result of a patent, we would need to write off the patent in the period we determine that the patent is impaired.*  At September 30, 2005, such a write-off would reduce our total assets by approximately $273,000.  It would have no effect on cash.  Costs of defending our patents are expensed as incurred, which, depending on the nature and complexity of the legal defense strategy, could materially impact our results of operations in any given period.*  

**Impairment of Long-Lived Assets**

Long-lived assets, including property and equipment and capitalized patents are amortized over their useful lives.  We assess the impairment of these assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable based on estimated undiscounted cash flows attributable to that asset.  The amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset.  Our judgments regarding the existence of impairment indicators are based on legal factors and market conditions.  Future events could cause us to conclude that impairment indicators exist and that certain assets are impaired.*  Such an adjustment would have no effect on our cash.*

**RESULTS OF OPERATIONS**

**The Results of Operations discussed below are presented in a format different than in prior periods to reflect the change in the Company’s business focus.  We present management’s discussion on the basis of Results of Ongoing Operations, Discontinued Operations, and Gain on Sale of Software Operations. **In order to provide comparative analysis, we also restate prior fiscal periods consistent with this presentation of discontinued operations and ongoing operations.

14

**Results of Ongoing Operations**

Revenue/Gross Profit (Loss)

|                        |   | **Three   Months Ended   September 30,** |   | **Change** |   | **Six Months   Ended   September 30,** |     | **Change** |     |
|-----------------------------|--------|------------------------------------------|--------|------------|--------|----------------------------------------|----------|------------|----------|
|                        |   |                                          |   |       |        |                                   |     |
|                        |   | **2005**                                 |   | **2004**   |   |                                   | **2005** |       | **2004** |   |   |
|                        |   |                                          |        |       |        |                                        |     |            |          |   |  |  |   |  |  |   |  |  |   |
| Patent license revenue      |   | $                                        | 272    |       | $      | —                       |     |       | N/A      |   | $ | 362 |   | $ | 3,092 |   |   | (88 | )% |
| Consulting revenue          |   |                                     | 621    |       |   | —                       |     |       | N/A      |   |   | 621 |   |   | —   |   |   | N/A |   |
| Patent amortization expense |   |                                     | (6,268 | )          |   | (5,487                                 | )        |       | 14       | % |   | (12,452 | ) |   | (10,890 | ) |   | 14 | % |
|                        |   |                                          |        |       |        |                                        |     |       |     |   |  |  |   |  |  |   |   |   |   |
| Gross profit (loss)         |   | $                                        | (5,375 | )          | $      | (5,487                                 | )        |       | 184      | % | $ | (11,469 | ) | $ | (7,798 | ) |   | (81 | )% |

We received nominal patent license revenues of $272 during the second quarter of fiscal 2006.  In the second quarter of fiscal 2005, no patent license revenue was earned.  For the comparative six-month periods, patent license revenue was $362 in fiscal 2006 compared to $3,092 in fiscal 2005.  Patent license revenue is very sporadic.  The timing of any significant fees usually corresponds to the settlement of litigation and, therefore, is unpredictable.  The patent license revenue in each of the comparable quarters and six-month periods represents ongoing royalties based on sales of product with a licensee with very low volumes.  While we intend to continue to pursue additional patent license agreements during fiscal 2006, we cannot predict the outcome of ongoing and future negotiations and there are no assurances that we will be successful in entering into additional patent licenses, or the timing or amount of any suchlicenses.*

Patent amortization expenses consist of amortization of capitalized costs of patent acquisition, filing and maintenance.  We capitalize the cost of procuring patents which mainly consists of attorney and filing fees.  Once a patent is granted, we also capitalize the expense of maintaining our registration in the various countries.  These costs are amortized over the remaining life of the various patents on a straight line basis.  The costs associated with litigation or negotiation of patent licenses with third parties is separately accounted for as “patent expenses” under ‘Operating Expense’ below.  Patent amortization expenses for the second quarter and the first six months of fiscal 2006 increased by 14% and 14%, respectively, over the comparable periods in fiscal 2005 due to patent related fees incurred during the second quarter which were amortized.

15

Operating Expense

|                           |   | **Three   Months Ended   September 30,** |    | **Change** |   | **Six Months   Ended   September 30,** |     | **Change** |     |
|--------------------------------|--------|------------------------------------------|---------|------------|--------|----------------------------------------|----------|------------|----------|
|                           |   |                                          |    |       |        |                                   |     |
|                           |   | **2005**                                 |    | **2004**   |   |                                   | **2005** |       | **2004** |   |   |
|                           |   |                                          |         |       |        |                                        |     |            |          |   |  |  |   |  |  |   |  |  |   |
| General &   administrative |   | $                                        | 145,692 |       | $      | 109,392                                |     |       | 33       | % | $ | 287,448 |   | $ | 280,030 |   |   | 3 | % |
| Patent                         |   |                                     | 39,745  |       |   | 33,503                                 |     |       | 19       | % |   | 72,213 |   |   | 75,020 |   |   | (4 | )% |
| Depreciation                   |   |                                     | 369     |       |   | 547                                    |     |       | (33      | )% |   | 738 |   |   | 1,093 |   |   | (32 | )% |
|                           |   |                                          |         |       |        |                                        |     |       |     |   |  |  |   |  |  |   |   |   |   |
| Total operating expense        |   | $                                        | 185,806 |       | $      | 143,442                                |     |       | 30       | % | $ | 360,399 |   | $ | 356,143 |   |   | 1 | % |

Expenses of ongoing operations in all periods reflect costs associated with pursuing licenses of the patents and the costs of maintaining the public entity.  

General and administrative expense consists of salaries, legal and accounting fees, rent, insurance and other expenses associated with maintaining the corporate entity.  For the three- and six-month periods ended September 30 in both fiscal 2006 and 2005, these expenses included the salaries of the CEO (a portion of which was allocated to patent expense), the controller, a receptionist and Director of Investor Relations.  Legal and accounting fees for the quarter ended September 30, 2005 included approximately $63,000 in professional fees as a one-time expense incurred in connection with the sale of our software business.  There was no similar expense in the comparable periods ended September 30, 2004.  For the remainder of fiscal 2006, we anticipate some additional accounting expenses in connection with several SEC filings and additional tax consulting associated with the sale to Global. 

We expect the general and administrative expense associated with our patent licensing business decrease in future periods.  This will most likely occur gradually as the remaining staff of four people decreases over time.  We anticipate that our controller will remain on the payroll through December 31, 2005.  Thereafter, we expect to require additional consulting expense for accounting advice; but not to the extent of the salary expense of a controller.  Also, our CEO has agreed to a reduced salary which we anticipate will take effect within 6 months of the closing of the sale of assets (August 31, 2005).  Finally, there will not be a requirement for a receptionist in future quarters.  By comparison, we had 29 employees at September 30, 2004.  We cannot as yet foresee the impact of the sale of our software business on insurance and audit fees for future periods.** 

Patent expense includes the costs of litigation and negotiations with respect to patent licenses.  Patent license expenses can vary dramatically quarter-to-quarter depending upon the level of activity required from legal counsel and experts.  In June 2005, we filed an action in the Federal District Court for the Western District of Washington against ProClarity Corporation alleging patent infringement, and seeking monetary damages and an injunction against ProClarity licensing certain of its products.  Nevertheless, patent expenses remained relatively flat during the three- and six-months ended September 30, 2005, as this case is being handled on a contingency fee basis.  We will, however, be responsible for costs as incurred.  For this reason, we expect patent expenses to increase in future periods as the costs of litigation increase.*  Additionally, in the event there is a monetary recovery, legal fees will be accrued as anexpense against such recovery.* 

Depreciation expense decreased in the quarter ended September 30, 2005 to $369 from $547 in the quarter ended September 30, 2004.  Amortization of intangible assets were $0 during the same periods due to the fact all intangible assets other than patents and goodwill have been fully amortized. 

16

**Results of Discontinued Operations **

|                                         |   | **Three   Months Ended   September 30,** |    |     |   | **Six Months   Ended   September 30,** |   |     |   |
|----------------------------------------------|--------|------------------------------------------|---------|----------|--------|----------------------------------------|--------|----------|--------|
|                                         |   |                                          |    |     |   |                                        |   |     |   |
|                                         |   | **2005**                                 |    | **2004** |   | **Change**                             |   | **2005** |   | **2004** |   | **Change** |   |
|                                         |   |                                          |         |     |        |                                        |   |          |        |   |  |  |   |  |  |   |  |  |   |
| (Loss) income from   Discontinued Operations |   | $                                        | (57,181 | )        | $      | 16,394                                 |   |     | (456   | )% | $ | (108,551 | ) | $ | (159,181 | ) |   | 31 | % |

Discontinued Operations consists of our prior software licensing operations (which were sold to Global pursuant to the Asset Purchase Agreement), presented in accordance with FASB 144.

For the quarter ended September 30, 2005, our total operating loss from discontinued operations was $57,000 compared to income of $16,000 for the quarter ended September 30, 2004.  For the comparative six months, we had a loss of $109,000 for September 30, 2005 compared to a loss of $159,000 for September 30, 2004.  The losses from our discontinued software operations for the three- and six-month periods ended September 30, 2005 reflect a substantial decrease in revenue (software licensing, maintenance and consulting), as well as significant costs associated with severance benefits, during the period.  The decrease in revenues from our discontinued operations during this period was due in part to our announcement in June 2005 of the proposed sale of our software operations to Global Software.  We believe this announcement and the process of negotiating and executing an asset purchase agreement was disruptive to our business and contributed to anumber of current and prospective software customers delaying ordering software or services from us.  

**Gain on Stock Sale and Asset Sale**

During the periods ended September 30, 2005, we recognized one-time gains from the sale of our software operations to Global Software, consisting of a gain of $1,287,000 from the Stock Sale, and a gain of $1,075,000 from the Asset Sale.  These gains reflect not only the receipt of cash and notes payable, but also the assumption of liabilities associated with the business segment; most notably the deferred income associated with ongoing maintenance obligations.  

As a result of the closing of the Stock and Asset sales, Timeline received net cash proceeds of $886,000 (after payment of $252,000 on the bridge loan previously made by Global to us in June 2005).  Offsetting this increase in cash was $81,000 of Analyst Financials Limited’s cash which was included in the assets sold to Global, and was no longer part of the consolidated group at September 30, 2005.  

The remaining consideration in the Stock and Asset sales included two notes receivable in principal amount totaling $1,000,000 and the assumption of liabilities (see Liquidity and Capital Resources below for detail on the terms of the notes receivable).  

Timeline also incurred approximately $47,000 in severance benefits and bonus payments associated with the sales, all of which are included in the expenses of discontinued operations.   

These gains are a one time event and no future gains are expected to be recorded from these transactions.*  The Asset Purchase Agreement for the sale of our software operations included certain standard indemnification obligations by us of Global Software; accordingly, there is a possibility of some future expenses associated with potential future indemnification claims against us.*  Following the closing of the Asset Sale, we and Global have agreed to approximately $56,000 in certain post-closing accounting adjustments in favor of Global, and these are reflected in notes payable on the September 30, 2005 balance sheet.  We have not recorded any provision for future adjustments or any indemnification expenses as we do not consider any such expenses to be probable or material.  

17

**Other Income and Expense**

Other income and expense (other than from the Stock Sale or Asset Sale) generated net income of $14,000 in the second quarter of fiscal 2006 compared to a loss of $5,000 in the second quarter of fiscal 2005.  For the six months ended September 30, 2005, we had net income of $11,000 compared to a loss of $5,000 for the six months ended September 30, 2004.  In all periods the major components of income and expense was from interest and foreign exchange transactions.     

**Income Tax**

No income tax expense was recorded in the comparable quarter or six-month periods of either fiscal 2006 or fiscal 2005.  All income or loss is offset by appropriate adjustments to the valuation allowance of our net operating loss carry-forwards.  The gain from the Stock Sale and the Asset Sale will also be offset by the net operating loss carry-forwards, so no net provision for tax expense has been provided.*  

**LIQUIDITY AND CAPITAL RESOURCES**

We have historically suffered recurring operating losses and negative cash flows from operations.   As of September 30, 2005, we had positive net working capital of approximately $784,000.  Additionally, as of September 30, 2005, our cash and cash equivalents were $790,000 compared to cash and cash equivalents of $121,000 as of March 31, 2005.  This increase was due to the receipt of net $805,000 cash proceeds from the sale of our software operations, offset by cash used in our discontinued operations and repayments under our former line of credit with Silicon Valley Bank and payment on a note payable to Global.

In addition, at September 30, 2005, we held two notes receivable from Global in principal amount totaling $1,000,000 from the sale of our software operations.  These notes receivable consist of (1) a $480,000 promissory note issued on July 20, 2005, with $240,000, plus accrued and unpaid interest, payable on January 20, 2007 and $240,000, plus accrued and unpaid interest, payable on July 20, 2008, and (2) a $520,000 promissory note issued on August 31, 2005, with $260,000, plus accrued and unpaid interest, payable on February 28, 2007 and $260,000, plus accrued and unpaid interest, payable on August 31, 2008.  Both promissory notes bear interest at a rate of 6% per annum, and are general unsecured obligations of Global.  These notes are subject to set off in the event of indemnification claims or other claims by Global against us under the Asset Purchase Agreement.  As of September 30, 2005, Global had not made any indemnificationclaims against us.

Accounts receivable were approximately $83,000 and $285,000 at September 30, 2005 and March 31, 2005, respectively.  All of these receivables were for software licenses and services generated by our discontinued software line of business but were not transferred as part of the asset sale to Global.

Total liabilities, excluding deferred revenue, were approximately $139,000 at September 30, 2005 compared to approximately $248,000 associated with ongoing operations at March 31, 2005.  The decrease in total liabilities is attributable to significant decreases in accounts payable and accrued expenses resulting from the sale of our software operations.  

18

With the net proceeds we received from the sale of software operations, as discussed in notes 1 and 6 to the financial statements included herein, we believe that our current cash and cash equivalents, together with any net cash provided by ongoing operations, will be sufficient to meet anticipated cash needs for working capital and capital expenditures through fiscal 2006.*  

**Other Factors That May Affect Operating Results**

Our operating results may fluctuate due to a number of factors, including, but not limited to, the following factors: 

|   | • | our patent licensing strategies regarding when and   the number of potential infringers we approach,     |
|--------|--------|----------------------------------------------------------------------------------------------------------|
|   | • | our ability to pursue and successfully negotiate   further patent licenses and generate patent revenues, |
|   | • | challenges to the validity of our patents,                                                               |
|   | • | costs of litigation associated with our patent   enforcement, and                                        |
|   | • | the cost of maintaining our public status.                                                               |

These factors are difficult for us to forecast, and can materially adversely affect our business and operating results for one quarter or a series of quarters.** 

| **Item 3.** | **Controls and Procedure** |
|-------------|----------------------------|

(a) Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this report, we performed an evaluation under the supervision and with the participation of management, including our Chief Executive Officer/Chief Financial Officers, of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)).  Based on this evaluation, we concluded that our disclosure controls and procedures are effective to ensure that information required to be disclosed in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.

(b) Changes in Internal Controls

During the most recent fiscal quarter,there were no significant changes in our internal controls over financialreporting or in other factors that have materially affected, or are reasonablylikely to materially affect our internal controls.

19

**PART II. – OTHER INFORMATION**

 

| **Item 6.** | **Exhibits** |
|-------------|--------------|

| Exhibits:               |
|-------------------------|
|                    |   |
|    3.1*  | Articles of Incorporation of Timeline, Inc., as   amended October 7, 2005. |
|                    |   |
|    21.1* | Subsidiaries of Timeline, Inc. |
|                    |   |
|    31.1  | Certification of Charles R. Osenbaugh, President, Chief   Executive Officer and Chief Financial Officer of Timeline, Inc. pursuant to   Section 302 of the Sarbanes-Oxley Act of 2002. |
|                    |   |
|    32.1  | Certification of Charles R. Osenbaugh, President,   Chief Executive Officer and Chief Financial Officer of Timeline, Inc.   pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the   Sarbanes-Oxley Act of 2002. |
|                    |   |

|   |
|---|
| * | Previously filed as an exhibit to, and incorporated   herein by reference from the Company’s Form 10-QSB for the quarter ended   September 30, 2005, filed November 11, 2005. |

20

**SIGNATURE**

In accordance with the requirements of the Exchange Act, the registrant caused this Amendment No. 2 to Form 10-QSB to be signed on its behalf by the undersigned, thereunto duly authorized.

|                            | Timeline, Inc. |
|---------------------------------|----------------|
|                            | (Registrant)   |
|                            |           |
| Date:    February 14, 2006 | By:            | /s/ Charles R. Osenbaugh |
|                            |           |  |
|                            |           | Charles R. Osenbaugh |
|                            |           | President/Chief Financial Officer |
|                            |           |   |
|                            |           | Signed on behalf of registrant and as principal   financial officer. |

21